Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
James Hawthorne, Dimos Katsaros, Amy Rinaldi, Katherine Brigham, Matthew D’Auria, Erika Bajars, Chris Franzese & Marty Coyne. (2022) The current paradigm for biologic initiation: a confirmatory quantitative analysis of self-injection training practices. Expert Opinion on Drug Delivery 19:6, pages 733-742.
Read now
Read now
Donghoon Shin, Younsoo Kim, Ahra Go & Maria Velinova. (2020) Comparison of the Pharmacokinetics, Safety, and Tolerability of the Autoinjector (AI) and Pre-Filled Syringe (PFS) of SB4 in Healthy Subjects. Drug Design, Development and Therapy 14, pages 43-50.
Read now
Read now
Naceur Rekaya, Alexandra Pickersgill & Louisa Harvey. (2019) Addition Of A Sleeve To The Etanercept Autoinjector (Enbrel® MyClic®) Improves Ease Of Use In Patients With Rheumatoid Arthritis. Medical Devices: Evidence and Research 12, pages 443-450.
Read now
Read now
Jeehoon Ghil, Agnieszka Zielińska & Younju Lee. (2019) Usability and safety of SB5 (an adalimumab biosimilar) prefilled syringe and autoinjector in patients with rheumatoid arthritis. Current Medical Research and Opinion 35:3, pages 497-502.
Read now
Read now
Bernd Tischer & Andrea Mehl. (2018) Patients’ and nurses’ preferences for autoinjectors for rheumatoid arthritis: results of a European survey. Patient Preference and Adherence 12, pages 1413-1424.
Read now
Read now
Donghoon Shin, Younju Lee, Deokyoon Jeong & Rod Ellis-Pegler. (2018) Comparative pharmacokinetics of an adalimumab biosimilar SB5 administered via autoinjector or prefilled syringe in healthy subjects. Drug Design, Development and Therapy 12, pages 3799-3805.
Read now
Read now
Zhaoyang Li & Rachael Easton. (2018) Practical considerations in clinical strategy to support the development of injectable drug-device combination products for biologics. mAbs 10:1, pages 18-33.
Read now
Read now
Barbara Domańska, Brenda VanLunen, Luke Peterson, Irina Mountian & Michael Schiff. (2017) Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis. Expert Opinion on Drug Delivery 14:1, pages 15-22.
Read now
Read now
David H. Collier, Bojena Bitman, Andrew Coles, Lyrica Liu, Sandeep Kumar & Clinton Judd. (2017) A novel electromechanical autoinjector, AutoTouch™, for self-injection of etanercept: real-world use and benefits. Postgraduate Medicine 129:1, pages 118-125.
Read now
Read now
André Frenzel, Thomas Schirrmann & Michael Hust. (2016) Phage display-derived human antibodies in clinical development and therapy. mAbs 8:7, pages 1177-1194.
Read now
Read now
Chika Ohata, Takako Shintani, Masataka Arakawa, Kazuhiro Yoshimura, Bungo Ohyama, Norito Ishii, Fumitake Ono, Takahiro Hamada, Tadashi Karashima & Minao Furumura. (2015) Frequent office visits for injections may reduce adalimumab survival rate in patients with psoriasis. Journal of Dermatological Treatment 26:4, pages 312-313.
Read now
Read now
Joaquín Borrás-Blasco, Antonio Gracia-Pérez, M Dolores-Elvira Casterá, J Dolores Rosique-Robles & Javier Abad. (2013) Educational session as a tool to increase patient satisfaction of switching etanercept from the prefilled syringe to the autoinjection pen. Expert Opinion on Biological Therapy 13:8, pages 1103-1108.
Read now
Read now
Hèctor Corominas, Silvia Garcia-Diaz, Lucinda Sanchez-Eslava & Ramon Fíguls. (2012) “Switching adalimumab from syringe to pen. Expected outcomes”. Expert Opinion on Biological Therapy 12:6, pages 805-806.
Read now
Read now
Peter Varunok, Eric Lawitz, Kimberly L Beavers, Gary Matusow, Ruby Leong, Nathalie Lambert, Coen Bernaards, Jonathan Solsky, Barbara J Brennan, Cynthia Wat & Anne Bertasso. (2011) Evaluation of pharmacokinetics, user handling, and tolerability of peginterferon alfa-2a (40 kDa) delivered via a disposable autoinjector device. Patient Preference and Adherence 5, pages 587-599.
Read now
Read now
Articles from other publishers (27)
Rieke Alten, Simon Moss, Stefanie Hahne, Angela T. Muriset, David Gruben & Mark Latymer. (2023) High Usability and Applicability Ratings for the New SmartClic®/ClicWise® Injection Device: Evidence from a Health Care Professional Opinion Study. Rheumatology and Therapy 10:2, pages 477-487.
Crossref
Crossref
Amy Perrin Ross, Christian Besser, Shubhanvita Naval, Dee Stoneman, Harriet Gaunt & Noreen Barker. (2023) Patient and nurse preference for Sensoready autoinjector pen versus other autoinjectors in multiple sclerosis: results from a pilot multicenter survey. BMC Neurology 23:1.
Crossref
Crossref
Joaquin Borrás‐Blasco, Esther Vicente‐Escrig, Francisco José Rodríguez‐Lucena, Ana García‐Monsalve, Elena Arroyo‐Domingo, Raul Ferrando‐Piqueres, Elvira Casterá & Andrés Navarro‐Ruiz. (2022)
Six months multicentre pilot open label single‐arm study to evaluate patient experience, acceptability and satisfaction of switching certolizumab pegol from a prefilled syringe or autoinjection pen to an
AVA
®
e‐Device
in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis patients
. Journal of Clinical Pharmacy and Therapeutics 47:12, pages 2345-2349.
Crossref
Crossref
Yifei Liu, Joakim Söderberg & Jingdong Chao. (2022) Adherence to and Persistence with Adalimumab Therapy among Swedish Patients with Crohn’s Disease. Pharmacy 10:4, pages 87.
Crossref
Crossref
Roy M. Fleischmann, Amy E. Bock, Wuyan Zhang, Charles M. Godfrey, Ivana Vranic, Carol Cronenberger & Eva Dokoupilová. (2022) Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis. Rheumatology and Therapy 9:3, pages 839-850.
Crossref
Crossref
Sang‐Hoon Lee, Yong‐Gil Kim, Seung‐Geun Lee, Soo Hyun Lee, Young‐Joo Kim, Ja‐Young Jeon, Joo‐Young Jo, Hyun‐Jeong Yoo, Juneyoung Lee & Tae‐Hwan Kim. (2022) Treatment pattern, satisfaction, and productivity loss of patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors in Korea: A multicenter cross‐sectional observational study. International Journal of Rheumatic Diseases 25:5, pages 523-531.
Crossref
Crossref
Ahad Sabet, Daniel S. Dickerson, Eugenia E. Kunina, Anna Lucia Buccarello & Joëlle Monnet. (2022) A Randomised Controlled Trial Comparing the Pharmacokinetics and Tolerability of the Proposed Adalimumab Biosimilar MSB11022 Delivered via Autoinjector and Pre-filled Syringe in Healthy Subjects. Rheumatology and Therapy 9:2, pages 693-704.
Crossref
Crossref
Antonia Davidson, Darin Brimhall, Jonathan Kay, Edward Keystone, Sang Joon Lee, Sung Hyun Kim, Yun Ju Bae, Eun Jin Choi & Daniel E. Furst. (2021) Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT‐P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects. British Journal of Clinical Pharmacology 87:11, pages 4323-4333.
Crossref
Crossref
Wenhui Zhang, Helen Tyrrell, Han Ting Ding, Jennifer Pulley, Audrey Boruvka, Rich Erickson, Mariam Abouhossein, Renato Ravanello & Meina Tao Tang. (2021) Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy Volunteers. Advances in Therapy 38:5, pages 2418-2434.
Crossref
Crossref
Helen Tyrrell, Renato Ravanello, Jennifer Pulley, Meina Tao Tang, Wenhui Zhang, Mariam Abouhossein & Swati Tole. (2021) An Open-Label Tolerability and Actual-Use Human Factors Study of Etrolizumab Autoinjector in Healthy Volunteers. Advances in Therapy 38:5, pages 2406-2417.
Crossref
Crossref
Justyna Roszkiewicz, Zbigniew Swacha & Elżbieta Smolewska. (2020) Prefilled pen versus prefilled syringe: a pilot study evaluating two different methods of methotrexate subcutaneous injection in patients with JIA. Pediatric Rheumatology 18:1.
Crossref
Crossref
Naceur Rekaya, Steven M. Vicik, Bors T. Hulesch & Laura L. McDonald. (2020) Enhancement of an Auto-Injector Device for Self-Administration of Etanercept in Patients With Rheumatoid Arthritis Confers Emotional and Functional Benefits. Rheumatology and Therapy 7:3, pages 537-552.
Crossref
Crossref
Christof Maucksch, Peer M. Aries, Silke Zinke & Ulf Müller-Ladner. (2020) Patient Satisfaction with the Etanercept Biosimilar SB4 Device, Among Rheumatoid Arthritis and Spondyloarthropathy Patients - A German Observational Study. The Open Rheumatology Journal 14:1, pages 7-14.
Crossref
Crossref
Cristina Gely, Laura Marín, Jordi Gordillo, Míriam Mañosa, Federico Bertoletti, Fiorella Cañete, Carlos González-Muñoza, Margalida Calafat, Eugeni Domènech & Esther Garcia-Planella. (2020) Impact of pain associated with the subcutaneous administration of adalimumab. Gastroenterología y Hepatología 43:1, pages 9-13.
Crossref
Crossref
Cristina Gely, Laura Marín, Jordi Gordillo, Míriam Mañosa, Federico Bertoletti, Fiorella Cañete, Carlos González-Muñoza, Margalida Calafat, Eugeni Domènech & Esther Garcia-Planella. (2020) Impact of pain associated with the subcutaneous administration of adalimumab. Gastroenterología y Hepatología (English Edition) 43:1, pages 9-13.
Crossref
Crossref
Agnès Portron, Paul Jordan, Kristy Draper, Christopher Muenzer, Daniel Dickerson, Thijs van Iersel & Carsten Hofmann. (2020) A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers. Clinical Therapeutics 42:1, pages 108-120.e1.
Crossref
Crossref
Steve Fenwick, Kunal Thakur & Duncan Munro. (2019) Nurse and Patient Perceptions and Preferences for Subcutaneous Autoinjectors for Inflammatory Joint or Bowel Disease: Findings from a European Survey. Rheumatology and Therapy 6:2, pages 195-206.
Crossref
Crossref
Steven Ramael, Benjamin Van Hoorick, Renger Tiessen, Thijs van Iersel, Viktoria Moschetti, Benjamin Lang, Ivo Sonderegger, Sabrina Wiebe, Bernd Liedert & Girish Jayadeva. (2018) Similar Pharmacokinetics of the Adalimumab (Humira®) Biosimilar BI 695501 Whether Administered via Subcutaneous Autoinjector or Prefilled Syringe (VOLTAIRE®-AI and VOLTAIRE®-TAI): Phase 1, Randomized, Open-Label, Parallel-Group Trials. Rheumatology and Therapy 5:2, pages 403-421.
Crossref
Crossref
Nikos Maniadakis, Emese Toth, Michael Schiff, Xuan Wang, Maria Nassim, Boglarka Szegvari, Irina Mountian & Jeffrey R. Curtis. (2018) A Targeted Literature Review Examining Biologic Therapy Compliance and Persistence in Chronic Inflammatory Diseases to Identify the Associated Unmet Needs, Driving Factors, and Consequences. Advances in Therapy 35:9, pages 1333-1355.
Crossref
Crossref
Raphael J. Dehoratius, Lawrence H. Brent, Jeffrey R. Curtis, Lorie A Ellis & Kezhen L. Tang. (2018) Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept. The Patient - Patient-Centered Outcomes Research 11:3, pages 361-369.
Crossref
Crossref
Kunal Thakur, Anna Biberger, Alexandra Handrich & Mourad Farouk Rezk. (2016) Patient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe. Rheumatology and Therapy 3:2, pages 245-256.
Crossref
Crossref
G. Candelas, V. Villaverde, S. García, M. Guerra, M. J. León & J. D. Cañete. (2016) Benefit of health education by a training nurse in patients with axial and/or peripheral psoriatic arthritis: A systematic literature review. Rheumatology International 36:11, pages 1493-1506.
Crossref
Crossref
Colin H. Ridyard, Dalia M. M. Dawoud, Lorna V. Tuersley & Dyfrig A. Hughes. (2016) A Systematic Review of Patients’ Perspectives on the Subcutaneous Route of Medication Administration. The Patient - Patient-Centered Outcomes Research 9:4, pages 281-292.
Crossref
Crossref
Diane V. Doughty, Corbin Z. Clawson, William Lambert & J. Anand Subramony. (2016) Understanding Subcutaneous Tissue Pressure for Engineering Injection Devices for Large-Volume Protein Delivery. Journal of Pharmaceutical Sciences 105:7, pages 2105-2113.
Crossref
Crossref
Kunal Thakur, Anna Biberger, Alexandra Handrich & Mourad Farouk Rezk. (2016) Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe. Rheumatology and Therapy 3:1, pages 77-89.
Crossref
Crossref
Nozomi Ami & Hideki Satou. (2015) The use of rat spinal reflexes to quantify injection pain. European Journal of Pharmaceutical Sciences 74, pages 36-39.
Crossref
Crossref
Maria López, Laura Moreno, Angelina Dosal, Marta Maria Pujol, Mercedes Vergara & Montserrat Gil. (2011) Interferon and the Fear of Needles. Gastroenterology Nursing 34:5, pages 384-388.
Crossref
Crossref